Playlist

Penems – Cell Wall Synthesis Inhibitors (Antibiotics)

by Pravin Shukle, MD

My Notes
  • Required.
Save Cancel
    Learning Material 2
    • PDF
      Slides CellWallSynthesis BacterialProteinSynthesis Antimicrobials.pdf
    • PDF
      Download Lecture Overview
    Report mistake
    Transcript

    00:01 Okay, so we've talked about the penicillins.

    00:03 We've talked about the cephalosporins let's move on to the penems.

    00:08 When you talk to your professors sometimes, they'll refer to penems as carbapenems but that's not quite technically correct.

    00:15 Penems include both of the sulfapenems and the carbapenems.

    00:19 The first of the sulfapenems is faropenem.

    00:22 Faropenem is an orally active unsaturated beta-lactam antibiotic.

    00:29 It's resistant to many different forms of extended spectrum beta-lactamases, so when we have agents that are failing because the bacteria is producing beta-lactamase, we can use this agent and it tends to work quite nicely. It has better chemical stability than most agents and the nice thing about this particular agent is we now have trials that show that in tuberculosis it was effective.

    00:55 We start treating patients in our community acquired pneumonia clinics with this agent and we're starting to see some people who have pulmonary TB being treated with faropenem.

    01:07 The carbapenems are probably quite familiar to you already.

    01:12 The most popular and most well-known of the carbapenems is imipenem.

    01:17 You've probably seen it used on your clinical rotations.

    01:20 When I was a resident this drug was just coming in and we used to nickname it guerillacilin because it was so powerful.

    01:27 It's chemically unique but it still has a beta-lactam ring so we sometimes worry about beta-lactamases.

    01:33 However, it does have a low susceptibility to those penicillinases so we can take some comfort in that.

    01:40 Unfortunately, it is susceptible to a different kind of enzyme produced by the kidney called dehydropeptidase.

    01:48 It's administered with cilastatin which is an inhibitor of that enzyme so we will see it administered as imipenem cilastatin.

    01:57 It's a wide ranging agent. We tend to use it against all kinds of organism that includes the gram positive cocci, the gram-negative rods, the anaerobic confections are often treated including intra-abdominal infections, and then of course it's active against pseudomonas and the Acinetobacter species as well, so you can see where in patients who are in the intensive care unit, let's say they're brought in with pneumo sepsis and they have a bleeding gut, imipenem is often used in this kind of a patient because we're really not sure what is going on in the patient so we wanna broad-spectrum powerful agent that has pseudomonas activity.


    About the Lecture

    The lecture Penems – Cell Wall Synthesis Inhibitors (Antibiotics) by Pravin Shukle, MD is from the course Antimicrobial Pharmacology.


    Included Quiz Questions

    1. Cilastatin
    2. Clavulanic acid
    3. Aminoglycosides
    4. Tazobactam
    5. Sulbactam
    1. They do not contain a beta-lactam ring.
    2. They are active against acinetobacter species.
    3. They are active against gram-negative rods.
    4. They are active against anaerobes.
    5. They have low susceptibility to penicillinases.

    Author of lecture Penems – Cell Wall Synthesis Inhibitors (Antibiotics)

     Pravin Shukle, MD

    Pravin Shukle, MD


    Customer reviews

    (1)
    5,0 of 5 stars
    5 Stars
    5
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1  Star
    0